By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Developing a treatment for ovarian cancer320K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
Denmark and the United States320K100.00%